
Under the auspices of

Jan 14-16, 2027 in Phoenix, AZ
THE 3RD SUMMIT OF LABORATORY & MEDICINE INNOVATIONS
ORGANIZING COMMITTEE
The 2027 meeting is hosted by Alliance for Laboratory Medicine Innovation (ALMI), supported by Foundation for Laboratory Medicine Innovation (FLMI).
Meeting Chair: Zhen Zhao, PhD, DABCC, Weill Cornell Medicine
Executive Chair: Jing Cao, PhD, DABCC, University fo Texas Southwestern Medical Center
Scientific Chair: Xin Yi, PhD, DABCC, Houston Methodist Hospital
Program Planning and Strategic Chair: Min Yu, MD, PhD, MBA, DABCC, Harvard Beth Israel Deaconess Medical Center
Section Chairs: ​
Genomics and Personalized Diagnostics: Zhenya Tang, MD, PhD, FACMG, University of Nebraska Medical Center
Transplant Precision Medicine: Dongfeng Chen, PhD, F(ACHI), Duke University Medical Center
Drug Use and Misuse: Yanwei Xi, DABMGG, FACMG, Children's Hospital of Eastern Ontario;
Fang Wu, PhD, DABCC, Harvard Brigham and Women’s Hospital
From AI to Advanced Diagnostics: Sabrina Racine-Brzostek, MD, Weill Cornell Medicine​
Bioengineering in Clinical Applications: Chao Wang, PhD, Arizona State University
From Technology to Clinical Solutions: Lingjun Li, PhD, The University of Wisconsin-Madison
FDA Regulation and Policy: Jinjie Hu, PhD, President, Axteria BioMed Consulting Inc.; CEO, ClearDx Labs
Intellectual Property & Patent: Lukas Pfannenstiel, PhD, Saul Ewing
Commercial Laboratory: Genomics and Metagenomics in Oncology: Xie Heng, PhD, MBA, Delve Bio
At-Home and Direct to Consumer Testing: Nicole Tolan, PhD, DABCC, Washington University
Human Microbiome and Infectious Disease: Stefan Riedel, MD, PhD, Beth Israel Deaconess Medical Center, Harvard Medical School
Cardiac Health & Chronic Disease Monitoring: Jing Cao, PhD, DABCC, University fo Texas Southwestern Medical Center
